PBAX Stock Price, News & Analysis

PBAX NASDAQ

Company Description

PBAX (NASDAQ: PBAX) is a publicly traded company.

PBAX stock has declined 100.0% over the past year.

This page provides a comprehensive overview of PBAX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

PBAX (PBAX) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

February 14, 2024

-100.00%

Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination

acquisition

June 5, 2023

0.00%

CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics

acquisition

November 22, 2021

—

Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021

acquisition

October 8, 2021

—

Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option

IPO offering acquisition

October 5, 2021

—

Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public Offering

IPO offering acquisition

PBAX has 5 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all PBAX news →

SEC Filings

View All

No SEC filings available for PBAX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months